
Pubmed-entry ::= {
  pmid 29969517,
  medent {
    em std {
      year 2018,
      month 7,
      day 4,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "A case of acute liver failure due to carfilzomib in multiple
 myeloma."
      },
      authors {
        names std {
          {
            name ml "Kathi PR",
            affil str "Wayne State University School of Medicine, Detroit,
 Michigan."
          },
          {
            name ml "Tama M",
            affil str "Wayne State University School of Medicine, Detroit,
 Michigan."
          },
          {
            name ml "Kundumadam S",
            affil str "Wayne State University School of Medicine, Detroit,
 Michigan."
          },
          {
            name ml "Naylor P",
            affil str "Wayne State University School of Medicine, Detroit,
 Michigan."
          },
          {
            name ml "Mutchnick M",
            affil str "Wayne State University School of Medicine, Detroit,
 Michigan."
          }
        }
      },
      from journal {
        title {
          iso-jta "J Clin Pharm Ther",
          ml-jta "J Clin Pharm Ther",
          issn "1365-2710",
          name "Journal of clinical pharmacy and therapeutics"
        },
        imp {
          date std {
            year 2018,
            month 12
          },
          volume "43",
          issue "6",
          pages "918-920",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2018,
                month 5,
                day 28
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2018,
                month 6,
                day 9
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 7,
                day 4,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 1,
                day 19,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 7,
                day 4,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29969517,
        doi "10.1111/jcpt.12741",
        other {
          db "ELocationID doi",
          tag str "10.1111/jcpt.12741"
        }
      }
    },
    abstract "WHAT IS KNOWN AND STUDY OBJECTIVE: Carfilzomib is a newer drug
 approved for the treatment of relapsing and refractory multiple myeloma. It
 has been rarely associated with acute liver failure (ALF). CASE SUMMARY: We
 present a case of 58-year-old man presenting with abnormal liver function
 tests and subsequently diagnosed with ALF due to carfilzomib. Liver enzymes
 improved significantly after discontinuation of the drug. WHAT IS NEW AND
 CONCLUSION: Even though ALF due to carfilzomib has been documented rarely in
 clinical studies, no detailed case report has been published so far. Patients
 on carfilzomib should be monitored for ALF, and prompt discontinuation of
 drug is necessary in such cases.",
    mesh {
      {
        term "Antineoplastic Agents",
        qual {
          {
            subh "administration & dosage"
          },
          {
            mp TRUE,
            subh "adverse effects"
          }
        }
      },
      {
        term "Chemical and Drug Induced Liver Injury",
        qual {
          {
            subh "etiology"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Liver Failure, Acute",
        qual {
          {
            mp TRUE,
            subh "chemically induced"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Liver Function Tests"
      },
      {
        term "Male"
      },
      {
        term "Middle Aged"
      },
      {
        term "Multiple Myeloma",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          }
        }
      },
      {
        term "Oligopeptides",
        qual {
          {
            subh "administration & dosage"
          },
          {
            mp TRUE,
            subh "adverse effects"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Antineoplastic Agents"
      },
      {
        type nameonly,
        name "Oligopeptides"
      },
      {
        type cas,
        cit "72X6E3J5AR",
        name "carfilzomib"
      }
    },
    pmid 29969517,
    pub-type {
      "Case Reports"
    },
    status medline
  }
}


